Posts

Refine Results:

Reset Filters

Displaying 1 - 25 of 39 results

Learning Drives Innovation in New PCORI Initiatives

Leadership Perspective
Our efforts to engage patients and stakeholders across the healthcare community, and focus on outcomes of interest to patients and those who care for them, are how we conduct Research…

Minority Health Month: Spotlight on COVID-19

Blog
Each week throughout April, in recognition of National Minority Health Month, PCORI will spotlight health conditions that disproportionately affect communities of color. One of PCORI's National Priorities for Health is…

Minority Health Month: Spotlight on Hypertension

Blog
Each week throughout April, in recognition of National Minority Health Month, PCORI will spotlight health conditions that disproportionately affect communities of color. One of PCORI's National Priorities for Health is…

Helping Make Veterans Research More Patient-Centered

Blog
One of the goals PCORI set in its strategic plan is to influence research to become more patient-centered. Engaging patients and healthcare stakeholders in the research process is central to…

PCORI-Funded Researchers Seek Ways to Address Youth Suicide

Blog
This month PCORI joins researchers, people with lived experience, health experts, medical professionals, and millions of other stakeholders to mark National Suicide Prevention Month. Suicide is the tenth leading cause…

PCORI approves $254 million to fund 28 new research studies addressing urgent health problems

News Release
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $254 million in funding for 28 new research studies aimed at eliminating disparities in maternal morbidity and mortality, preventing suicide among young people, and improving behavioral health, maternal and infant outcomes, cancer care, surgical care and outcomes for people with chronic illnesses such as cardiovascular disease and diabetes.

Lower- and higher-dose aspirin achieve similar protection and safety for people with cardiovascular disease

News Release
People with cardiovascular disease (CVD) taking aspirin to lower their chances of suffering a heart attack or stroke experienced similar health benefits, including reduced death and hospitalization for heart attack and stroke, whether they took a high or low dose of aspirin, according to a study presented today at ACC.21, the American College of Cardiology’s 70th Annual Scientific Session and published in the New England Journal of Medicine.

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.

Subscribe to PCORI Emails

Image

Hand pointing to email icon